December 13, 2024

New Vaccine Prevents Severe RSV Illness

A recent study showed the new vaccine was more than 90% effective in the prevention of hospitalizations and emergency department visits due to RSV among those 60 years old or older.

Conexiant

December 13, 2024

Billions Carry Herpes, Study Reveals

Two-thirds of the global population carry HSV, with distinct patterns of oral and genital infections across regions and age groups.

Conexiant

December 12, 2024

Trump, RFK Jr. Eye Vaccine Policies

Trump plans to discuss vaccine programs with RFK Jr., citing potential risks and the autism rate as key concerns.

Reuters

December 12, 2024

54 Novel Drugs Await FDA Review

An analysis published in the American Journal of Health-System Pharmacy provides an overview of the potential next wave of pharmaceuticals.

Conexiant

December 12, 2024

FDA Monitoring Ocaliva for Liver Injury

Reuters

December 11, 2024

Blinatumomab Enhances Disease-Free Survival in B-Cell ALL: Study

Conexiant

December 10, 2024

Biomarkers in Familial Mediterranean Fever: Therapy Insights

Conexiant

December 10, 2024

USPSTF Issues Draft Cervical Cancer Guidelines

For the first time, the Task Force has endorsed self-collected HPV testing.

Conexiant

December 09, 2024

Do SGLT2i, GLP-1 RAs Cut Pneumonia, Sepsis Risk?

In the largest real-world study to date, GLP-1 receptor agonists reduced pneumonia risk by 40% in type 2 diabetes patients.

Conexiant